| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Steven J. Shulman | Director | 04 Jan 2022 | |||
| Christopher J. Chen | Director | 04 Jan 2022 | |||
| Leslie Norwalk V | Director | 04 Jan 2022 | |||
| Mural R. Josephson | Director | 04 Jan 2022 | |||
| Jeffrey N. West | SVP & Controller | 04 Jan 2022 | |||
| James E. Murray | President and COO | 02 Jan 2022 | |||
| Kenneth J. Fasola | Chief Executive Officer, Director | 04 Jan 2022 | |||
| G. Scott MacKenzie | Director | 04 Jan 2022 | |||
| Peter A. Feld | Director | 04 Jan 2022 | |||
| Guy P. Sansone | Director | 04 Jan 2022 | |||
| Swati Bargotra Abbott | Director | 04 Jan 2022 | |||
| Clapper Caskie Lewis | Chief Human Resources Officer | 04 Jan 2022 | |||
| David Haddock | General Counsel & Secretary | 04 Jan 2022 | |||
| Mostafa Kamal | CEO, Magellan Rx Management | 04 Jan 2022 | |||
| David Bourdon | Chief Financial Officer | 04 Jan 2022 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||